Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis
- 作者: Vorob'eva N1, Ermolina O1, Balakhonova T1, Dobrovol'skiĭ A1, Titaeva E2, Kirienko A2, Panchenko E1
-
隶属关系:
- ФГУ Российский кардиологический научно-практический комплекс Росздрава
- РГМУ им. Н. И. Пирогова, Москва
- 期: 卷 80, 编号 7 (2008)
- 页面: 50-54
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30206
- ID: 30206
如何引用文章
全文:
详细
作者简介
N Vorob'eva
ФГУ Российский кардиологический научно-практический комплекс Росздрава
O Ermolina
ФГУ Российский кардиологический научно-практический комплекс Росздрава
T Balakhonova
ФГУ Российский кардиологический научно-практический комплекс Росздрава
A Dobrovol'skiĭ
ФГУ Российский кардиологический научно-практический комплекс Росздрава
E Titaeva
РГМУ им. Н. И. Пирогова, Москва
A Kirienko
РГМУ им. Н. И. Пирогова, Москва
E Panchenko
ФГУ Российский кардиологический научно-практический комплекс Росздрава
参考
- Büller Н. R., Agnelli G., Hull R. D. et al. Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 401S-428S.
- Schulman S., Rhedin A. S., Lindmarker P. et al. A comparison of six weeks with six months of oral anticoagulant therapy after а first episode of venous thromboembolism: Duration of Anticoagulation Trial Study Group. N. Engl. J. Med. 1995; 332: 1661-1665.
- Kearon C., Gent M., Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N. Eng. J. Med. 1999; 340: 901-907.
- Fihn S. D., McDonnel M., Martin D. et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann. Intern. Med. 1993; 118: 511-520.
- Timinski U., Rabe E. Results of the D-dimer test during the anticoagulation therapy of deep vein thrombosis. Vasomed. 1999; suppl. 1: 49.
- Cosmi B. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes. J. Tromb. Haemost. 2006; 4: 2527-2529.
- Palareti G., Legnani C., Cosmi B. et al. D-dimer testing to determine the duration of anticoagulation therapy. N. Eng. J. Med. 2006; 355: 1780-1789.
- Eichinger S., Minar E., Bialonezyk C. et al. D-dimer levels and risk of recurrent venous thromboembolism. J. A. M. A. 2003; 290: 1071-1074.
- Fattorini A., Crippa L., Vigano d'Angelo S. et al. Risk of deep vein thrombosis recurrence: high negative predictive value of D-dimer performed during oral anticoagulation. Thromb. Haemost. 2002; 88:162-163.
- Панченко E. П., Кропачева E. С. Профилактика тромбоэмболии у больных мерцательной аритмией. М.: ООО "МИА"; 2007.
- Kamali F. Genetic influences on the response to warfarin. Curr. Opin. Hematol. 2006; 13: 357-361.
- Levine M. N., Raskob G., Beyth R. J. et al. Hemorrhagic complication of anticoagulant treatment. Chest 2004; 126: 287S-310S.
- Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). Int. Angiol. 2006; 25: 101-161.